These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2941294

  • 1. Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis.
    Van Poppel H, Wegge M, Dammekens H, Chysky V.
    Eur J Clin Microbiol; 1986 Apr; 5(2):251-3. PubMed ID: 2941294
    [No Abstract] [Full Text] [Related]

  • 2. Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria.
    Guibert J, Destrée D, Konopka C, Acar J.
    Eur J Clin Microbiol; 1986 Apr; 5(2):247-8. PubMed ID: 2941292
    [No Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.
    Mehtar S, Drabu Y, Blakemore P.
    Eur J Clin Microbiol; 1986 Apr; 5(2):248-51. PubMed ID: 2941293
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experience with gentamicin in chronic urinary tract infections].
    Urlesberger H, Zechner E.
    Wien Med Wochenschr; 1969 Nov 01; 119(44):755-6. PubMed ID: 5362168
    [No Abstract] [Full Text] [Related]

  • 5. Management of Urinary tract infections in the nursing home elderly: a proposed algorithmic approach.
    Beier MT.
    Int J Antimicrob Agents; 1999 May 01; 11(3-4):275-84. PubMed ID: 10394983
    [Abstract] [Full Text] [Related]

  • 6. Evaluation and treatment of urinary infection.
    Riff LJ.
    Med Clin North Am; 1978 Nov 01; 62(6):1183-99. PubMed ID: 368444
    [No Abstract] [Full Text] [Related]

  • 7. Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.
    Saavedra S, Ramírez-Ronda CH, Nevárez M.
    Eur J Clin Microbiol; 1986 Apr 01; 5(2):255-7. PubMed ID: 2941296
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical trial of rifampicin in the treatment of acute and chronic sepsis of the urogenital tract].
    Valentino RV.
    Minerva Urol; 1968 Apr 01; 20(1):33-41. PubMed ID: 4188535
    [No Abstract] [Full Text] [Related]

  • 9. Ten years of ciprofloxacin: the past, present and future. Genitourinary infections. Introduction.
    Grüneberg R.
    J Antimicrob Chemother; 1999 Mar 01; 43 Suppl A():65. PubMed ID: 10225574
    [No Abstract] [Full Text] [Related]

  • 10. The bacteriological diagnosis and treatment of urinary tract infection.
    Motzkin D.
    J Urol; 1972 Mar 01; 107(3):454-7. PubMed ID: 4551629
    [No Abstract] [Full Text] [Related]

  • 11. Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin.
    Van Poppel H, Wegge M, Dammekens H, Chysky V.
    Chemotherapy; 1986 Mar 01; 32(1):83-7. PubMed ID: 2936583
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic effects of lividomycin in urinary tract infections caused by Pseudomonas aeruginosa].
    Tanaka E, Nakazawa S, Sato H.
    Jpn J Antibiot; 1972 Dec 01; 25(6):446-51. PubMed ID: 4198944
    [No Abstract] [Full Text] [Related]

  • 13. Urinary tract infections.
    Rubinoff H.
    Prim Care; 1977 Dec 01; 4(4):617-28. PubMed ID: 243908
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis.
    Greenwood D, Baxter S, Cowlishaw A, Eley A, Slater GJ.
    Eur J Clin Microbiol; 1984 Aug 01; 3(4):351-4. PubMed ID: 6489325
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial therapy for urinary tract infections.
    Kim ED, Schaeffer AJ.
    Semin Nephrol; 1994 Nov 01; 14(6):551-69. PubMed ID: 7855462
    [No Abstract] [Full Text] [Related]

  • 16. [Ciprofloxacin--a new antibacterial drug].
    Lewandowski A.
    Wiad Lek; 1985 May 01; 38(9):649-52. PubMed ID: 2930951
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients.
    Naber KG, Witte W, Bauernfeind A, Wiedemann B, Wagenlehner F, Klare I, Heisig P.
    Infection; 1994 May 01; 22 Suppl 2():S122-7. PubMed ID: 7927830
    [Abstract] [Full Text] [Related]

  • 18. Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection.
    Peters HJ.
    Eur J Clin Microbiol; 1986 Apr 01; 5(2):253-5. PubMed ID: 2941295
    [No Abstract] [Full Text] [Related]

  • 19. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M, Bontemps S, Dessein R, Angoulvant F, Madhi F, Martinot A, Cohen R, Dubos F, GPIPGroupe de pathologie infectieuse pédiatrique (Paediatric Infectious Disease Group), France..
    Med Mal Infect; 2018 May 01; 48(3):193-201. PubMed ID: 29449049
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections: a central military hospital study.
    Timko J.
    Chin Med J (Engl); 2014 May 01; 127(23):4150-1. PubMed ID: 25430467
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.